Learn about the current evidence on breast implant illness, its symptoms, diagnosis, treatment options, and what to expect after implant removal.

Choosing breast implants is a deeply personal decision. For some women, they represent an opportunity to regain confidence after pregnancy, significant weight loss, or breast reconstruction. Therefore, when unexplained symptoms begin to appear, it's natural to wonder if the implants might be involved.
The callbreast implant illnessBreast Implant Illness (BII), also known as Breast Implant Illness, describes a broad range of symptoms that some patients attribute to their implants. Persistent fatigue, muscle or joint pain, difficulty concentrating, sleep disturbances, skin changes, and a general feeling of malaise are some of the symptoms that have been reported.
The difficulty lies in the fact that these symptoms are nonspecific. They can appear for numerous reasons, and currently, there is no single medical test that can confirm a patient has BII. Scientific evidence continues to evolve, and important questions remain about its causes and mechanisms.
Dr. García Rodríguez understands that a patient with persistent symptoms needs to be listened to and evaluated holistically. The goal is not to automatically attribute every symptom to the implants, but to investigate its possible causes, rule out other conditions, and discuss the available alternatives with the patient.
The breast implant illnessIt is not currently a disease with universally accepted diagnostic criteria. The term BII is used to describe a group of systemic symptoms that some women experience after receiving breast implants and which they consider related to them.
The FDA acknowledges that patients with silicone and saline implants have reported systemic symptoms such as fatigue, memory loss, difficulty concentrating, joint pain, skin rashes, and what some patients describe as "brain fog." These symptoms can appear shortly after implant placement or years later.
However, acknowledging these reports does not mean that implants have been proven to be the cause of every symptom. The relationship continues to be investigated, and for an individual patient, it can be difficult to establish a direct causal link.
This distinction is important because it allows us to address the problem seriously without minimizing the experiences of patients or automatically attributing all their symptoms to the implants.
The symptoms associated with BII can vary considerably from patient to patient. There is no single combination that allows for a definitive diagnosis of the disease.
One of the most frequently reported manifestations is aPersistent fatigue or a general feeling of exhaustionwhich does not seem to be easily explained by rest, activity level or the patient's usual circumstances.
A recently published systematic review and meta-analysis found that fatigue or malaise, muscle pain or weakness, and cognitive impairment were among the symptoms most strongly associated with the presence of implants in the analyzed studies.
Some patients report muscle and joint pain, stiffness, or a feeling of weakness. These symptoms can have multiple causes, so it's important to have a medical evaluation before assuming they are related to the implants.
The call“brain fog”It can be described as difficulty concentrating, remembering information, or maintaining mental clarity. It is also a symptom that can appear in various illnesses, sleep disorders, hormonal changes, stress, and other medical conditions.
Skin rashes, hair loss, weight changes, anxiety, depression, headaches, and other systemic symptoms have also been reported. The FDA notes that these reports have been observed with various types of implants, regardless of the filling material, shape, or surface.
The research on thedisease caused bybreast implantsIt has increased considerably, but there are still important limitations.
A systematic review published in 2024 included 31 studies and more than 39,000 patients with implants. Among the studies that evaluated patients after removal, a significant proportion reported improvement in their symptoms. However, the authors also noted the need for further research into this condition and its mechanisms.
Another systematic review and meta-analysis published later analyzed 36 articles and more than 10,500 patients. It found associations between implants and symptoms such as fatigue, muscle symptoms, and cognitive impairment, although these results alone do not establish that implants are the direct cause of these symptoms.
The most recent literature continues to indicate that the cause of BII remains unresolved. Possible immunological, inflammatory, and other mechanisms have been studied, but there is still no single proven mechanism that explains all cases.
That's why, The current evidence must be interpreted with balance.There is enough information to take the symptoms reported by patients seriously, but there is still no diagnostic test or definitive scientific explanation applicable to all of them.
At the moment, There is no specific test to diagnose BIIThe diagnosis requires an individualized clinical evaluation.
The doctor should analyze when the symptoms started, how they have evolved, what medications the patient is using, her medical history, and whether there are other possible explanations.
Laboratory tests or consultation with specialists may also be necessary to rule out autoimmune, endocrine, inflammatory, or other conditions that can produce similar symptoms. The ASPS also notes that, due to the overlap of symptoms with other diseases, it is important to conduct a thorough evaluation before attributing them to the implants.
This process is important both for patients who wish to keep their implants and for those who are considering removing them.
This is one of the questions that most concerns patients. So far,The FDA has not established an association between silicone implants and connective tissue diseases.However, he acknowledges that some patients have reported systemic symptoms and that the investigation is ongoing.
This means that a patient presenting with autoimmune symptoms should not automatically assume that her implants are the cause. Similarly, her symptoms should not be dismissed simply because there is no specific BII test.
An individualized medical evaluation allows for the responsible investigation of both possibilities.
An implant rupture is a different complication from breast implant disease, although it may coexist with symptoms or discomfort.
In the case of implants silicone rupture can be intracapsular, when the gel remains inside the capsule surrounding the implant, or extracapsular, when the gel passes through that capsule and can migrate to nearby or more distant tissues.
Some ruptures may not produce any obvious symptoms. For this reason, follow-up appointments for implants and the imaging studies recommended by the surgeon are important.
When a rupture is suspected, the doctor may recommend studies such as ultrasound or MRI depending on the case.
It is essential not to confuse thebreast implant illnesswith BIA ALCL.
BIA ALCL is a rare type of lymphoma associated with breast implants. It is not breast cancer, but rather a cancer of the immune system. It has been observed more frequently in patients who have or have had textured implants.
Its manifestations may include persistent increase in breast size, fluid accumulation around the implant, lump, pain, or breast changes that appear even years after implant placement.
If a patient presentspersistent inflammation, a lump, new pain, or significant changes in a breastYou should consult your doctor for a proper evaluation.
BII and BIA ALCL are different situations and require different evaluation processes.
The treatment depends on the symptoms, medical findings, the condition of the implants, and the patient's preferences.
When a patient presents with systemic symptoms, the first step is not necessarily to remove the implants. It is important to investigate other potential causes and treat any identified conditions.
This evaluation may include laboratory tests, imaging studies, or assessment by other specialists when necessary.
A patient without significant symptoms can continue with her implants and attend the checkups recommended by her doctor. Implants are not considered permanent devices and may require follow-up or additional surgery over time.
Some patients who experience persistent symptoms decide to have their implants removed after discussing the benefits, risks, and expectations with their surgeon.
The available evidence shows thatA significant proportion of patients report improvement after extractionHowever, this does not mean that all patients will improve or that the extraction can guarantee the disappearance of all symptoms.
The decision must be individualized.
The capsule is the scar tissue that the body forms around the implant. Some patients consider a capsulotomy in addition to implant removal, butThere is no single technique that is appropriate for all patients with symptoms attributed to BII.
The choice between different types of capsulotomy depends on factors such as anatomy, the presence of capsular contracture, the condition of the implant, surgical history, and the patient's goals.
Furthermore, more extensive procedures may involve additional risks. Therefore, the technique should be decided after an individualized surgical assessment and not solely based on the BII label.
Some patients report a significant improvement in their symptoms after the extraction, while others experience partial improvement or no significant changes.
A recent systematic review found that a high proportion of patients reported improvement after explantation, but variability between studies and methodological limitations mean that these results cannot be interpreted as an individual guarantee.
The aesthetic outcome must also be considered. Depending on the size of the implants, the amount of breast tissue, skin elasticity, and how long the implants have been in place, removal can result in changes to the shape or volume of the breasts.
The surgeon may discuss options such as extraction without replacement, a surgical procedurebreast liftor other reconstructive alternatives, depending on each case.
A patient should consult a doctor if she develops persistent symptoms or new changes that concern her. This includes systemic symptoms that affect her quality of life, but also changes specifically related to her symptoms.mamas.
A mamaAny unexpected increase in size, a new mass, persistent pain, significant hardening, changes in shape, or fluid accumulation requires medical evaluation. These symptoms do not automatically indicate a serious complication, but they warrant an assessment.
The best strategy isDo not ignore the symptoms, and do not immediately assume their cause..
BII is a term used to describe a set of symptoms reported by patients with implants. However, there is currently no specific diagnostic test or universal criteria to confirm BII as a distinct disease. Research continues to better understand its causes and mechanisms.
Some patients with implants report fatigue, muscle and joint pain, and other systemic symptoms. Recent studies have found associations between these symptoms and the presence of implants, but an association does not prove that the implants are the direct cause in every patient.
Some patients report partial or complete improvement after implant removal. Systematic reviews have found significant improvement rates, but results vary, and removal does not guarantee that all symptoms will disappear.
No. The decision must be individualized. First, it's important to evaluate the symptoms, rule out other causes, and check the condition of the implants. If the patient is considering removal, she should discuss the potential benefits, risks, and aesthetic consequences with her surgeon.
No. BII refers to a set of systemic symptoms reported by some patients. BIA ALCL is a rare type of lymphoma primarily associated with textured surface implants. These are different conditions and require different evaluations.
The best course of action is to schedule a medical evaluation. Bring information about the type and age of your implants and explain when the symptoms began. The doctor can assess the condition of the implants, investigate other possible causes, and discuss the available options with you.
The breast implant illnessThis remains an evolving issue. Current evidence acknowledges that some patients experience systemic symptoms they attribute to their implants, and that a significant proportion report improvement after their removal. At the same time, science has not yet identified a single cause or a diagnostic test that can explain all cases.
Therefore, the best decision doesn't stem from fear or a generalized response. It stems from a careful medical evaluation, understanding the risks and benefits of each alternative, and having realistic expectations about what can be achieved with the treatment.
He Dr. García RodríguezShe can assess your symptoms, check the condition of your implants, and help you understand the options available for your situation. If you're considering removal, she can also explain what to expect from the procedure and how to preserve, as much as possible, a breast appearance that makes you feel comfortable and confident.
If you have symptoms that concern you or are considering removing your implants, schedule a consultation with Dr. García Rodríguezto receive a personalized assessment and make an informed decision about your health and well-being.